Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683512 · ClinicalTrials.gov registry record
GBE Deficiency (GSD IV and APBD) Natural History Study
A clinical trial of Glycogen Storage Disease Type IV and Adult Polyglucosan Body Disease, sponsored by Duke University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT02683512 is a study of Glycogen Storage Disease Type IV and Adult Polyglucosan Body Disease that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02683512, a study of Glycogen Storage Disease Type IV and Adult Polyglucosan Body Disease, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or Adult Polyglucosan Body Disease (APBD generated during clinic visits.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-12 |
| Est. Completion | 2035-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02683512
The ClinicalTrials.gov registry entry for NCT02683512 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Glycogen Storage Disease Type IV appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT02683512 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02683512 about?
NCT02683512 is a clinical study titled "GBE Deficiency (GSD IV and APBD) Natural History Study". Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or Adult Polyglucosan Body Disease (APBD generated during clinic visits.
What is the current status of trial NCT02683512?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2015-12. Estimated completion is 2035-12.
What conditions does trial NCT02683512 study?
This clinical trial studies the following conditions: Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease, GSD4, GSD IV, APBD.
What interventions are being tested in trial NCT02683512?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02683512?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02683512 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Glycogen Storage Disease Type IV
All registered trials for this condition
Adult Polyglucosan Body Disease
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.